BRCA1 and BRCA2 are human genes that produce tumor suppressor proteins. Men with harmful BRCA1 or BRCA2 mutations have a higher risk of prostate cancer.
A Toronto Women’s College Hospital research study, The Screen Project, provides Canadians access to affordable population-based genetic testing for the BRCA gene mutation.